Bio-Rad to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023

To participate, call 833-470-1428 within the U.S. or +1 929-526-1599 outside the U.S., access code: 522530. A live webcast of the conference call will also...

April 13, 2023 | Thursday | News
Sana Biotech's Hypoimmune Pancreatic Cells Control Type 1 Diabetes in Preclinical Model

Hypoimmune human islet cells normalized glucose in diabetic humanized immunocompetent mouse model and avoided allogeneic and autoimmune rejection by the im...

April 13, 2023 | Thursday | News
RxToolKit and NeuroNet Pro Announce Partnership to Improve Clinical Education and Safety for Neurology Practices

This collaboration extends preferred pricing on RxToolKit's software solutions in addition to other exclusive benefits already available to NeuroNet Pro me...

April 12, 2023 | Wednesday | News
Karmanos Cancer Institute invests in software to identify and manage patients at high risk of developing breast cancer

The Barbara Ann Karmanos Cancer Institute, a leading breast cancer prevention and care provider, has adopted Volpara® Risk Pathways™, a market-le...

April 12, 2023 | Wednesday | News
Cognizant and Boehringer Ingelheim Collaborate on Unified Cloud Platform to Speed the Delivery of Life Saving Therapies

Cognizant (NASDAQ: CTSH) announced it is working with Boehringer Ingelheim, a leading research-driven biopharmaceutical company, to advance the speed and q...

April 12, 2023 | Wednesday | News
COVID -19 Recommendations Map offers accessible pandemic guidelines

The RecMap is available here = https://covid19.recmap.org The RecMap is a one-stop shop for clinical, public health and health policy COVID-19 recommendat...

April 12, 2023 | Wednesday | News
Science 37 Unveils Three Global Centers of Excellence to Drive Efficiency, Speed and Quality

- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today unveiled three global Centers of Excellence (COEs) to gain greater ...

April 12, 2023 | Wednesday | News
ClearPoint Neuro extends agreement with Philips to include automatic subnuclei segmentation for DBS

The design goal of the ClearPoint Maestro® Brain Model is to enable highly accurate ClearPoint interventions under both MRI and CT guidance by facilit...

April 12, 2023 | Wednesday | News
Ocugen to Host Virtual Investor & Analyst Event on April 14, 2023

Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell th...

April 12, 2023 | Wednesday | News
ProMIS Neurosciences Announces Submission of Investigational New Drug (IND) Application for Lead Antibody PMN310

“This submission is an important milestone for the ProMIS team as we advance our lead compound, PMN310, toward the clinic. We are excited to continue...

April 11, 2023 | Tuesday | News
Nuvectis Pharma begins Phase 1b study for NXP800 in ARID1a-Mutated Ovarian Cancer

Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative pre...

April 11, 2023 | Tuesday | News
Hillstream BioPharma Announces Pharmacokinetic Data of HSB-1216 Supportive of its Development Strategy and Pre-clinical Data

Hillstream BioPharma, Inc. (Nasdaq: HILS) ("Hillstream" or the "Company"), a biotechnology company developing a portfolio of therapeutic candidates targeti...

April 11, 2023 | Tuesday | News
Sanofi withdraws and refills Premerger Notification under HSR Act, extends tender offer for Provention Bio.

As previously announced on March 24, 2023, Sanofi commenced a cash tender offer to purchase all outstanding shares of common stock of Provention Bio, Inc. ...

April 11, 2023 | Tuesday | News
UM School of Medicine Researchers Chart Path Forward on Developing mRNA Vaccines for Infections Beyond COVID-19

After helping to develop and test new mRNA technologies for COVID-19 vaccines, University of Maryland School of Medicine (UMSOM) researchers and scientists...

April 10, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close